查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572041

Antipilin 市場：按產品類型、應用、最終用戶、分銷管道、年齡層、治療層級- 2025-2030 年全球預測

Antipyrine Market by Product Type (Capsules, Injectable, Liquid), Application (Anti-Inflammatory, Arthritis, Cold and Flu), End User, Distribution Channel, Age Group, Therapeutic Class - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Antipilin市值為3.6322億美元，預計2024年將達3.8299億美元，複合年成長率為4.34%，到2030年將達到4.8929億美元。

安替比林是主要用作鎮痛劑和解熱劑的藥物化合物，在醫學領域具有多種用途。對抗毛蟲素的需求源自於其緩解疼痛和退燒的能力，使其成為多種非處方藥和處方藥配方中的重要成分。最終用途範圍主要包括配製為滴耳劑以緩解耳痛和發炎，以及由於其藥物動力學特性而在診斷應用中的潛在用途。根據市場洞察，抗毛蟲素的成長受到耳部感染疾病盛行率的增加、對有效疼痛管理解決方案的需求不斷成長以及藥物輸送系統的進步等因素的影響。安替比林的潛力在於探索其在新藥物組合和配方中的作用，以滿足不斷成長的消費者群體尋求更全面的止痛選擇的需求。這包括利用奈米技術的新研究來提高基於安替比林的藥物的生物有效性和功效，特別是作為標靶治療。然而，市場面臨著嚴格的法律規範、長期使用的潛在副作用以及來自替代療法的競爭等挑戰，這些都限制了成長。為了抓住新的機遇，公司必須專注於藥物輸送和個人化醫療的創新，以滿足特定族群的需求。與研究機構合作詳細研究其機制並發現新的治療適應症將帶來突破並增加我們在市場上的影響力。此外，在服務不足的市場中建立策略夥伴關係和擴大地理覆蓋範圍可能會支持成長。市場競爭激烈，但未來性，行業參與者保持適應性和主動性，確保合規性並解決安全問題，同時探索創新應用並提高市場相關性。

主要市場統計
基準年[2023] 3.6322 億美元
預計年份 [2024] 38299萬美元
預測年份 [2030] 4.8929 億美元
複合年成長率（%） 4.34%

市場動態：揭示快速發展的抗毛林市場的關鍵市場洞察

供需的動態交互作用正在改變抗毛蟲素市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大以發炎作用為重點的研究活動。
    • 抗皮林非處方藥需求不斷成長影響市場動態
    • 越來越關注抗毛蟲藥物聯合治療的開發，以獲得更好的臨床結果
    • 政府對抗毛蟲非專利藥開發的舉措和財政支持推動了市場成長
  • 市場限制因素
    • 加強對抗毛蟲藥物潛在副作用和安全問題的審查和公眾意識，影響消費者信心和銷售；
    • 生產反皮林所需的優質原料的採購和穩定供應面臨挑戰。
  • 市場機會
    • 由於醫療保健投資增加，對抗皮林藥物製劑的需求增加
    • 由於寵物擁有率上升，抗毛菌素在動物用藥品中的使用擴大
    • 由於人口老化，疼痛管理解決方案對安替比林的需求不斷成長
  • 市場挑戰
    • 應對抗毛蟲素產業供應鏈中斷及原物料價格波動
    • 介紹抗毛蟲生產流程中最尖端科技進步與創新

波特的五力：駕馭安匹林市場的策略工具

波特的五力框架是了解 Antipilin 市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 Antipilin 市場的外部影響

外部宏觀環境因素對塑造抗皮林市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解抗匹林市場競爭狀況

Antipilin 市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 Antipilin 市場供應商的績效評估

FPNV定位矩陣是評估安替匹林市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了抗皮林市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對 Antipilin 市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大抗發炎菌素抗發炎特性的研究力度
      • 非處方藥需求的成長影響市場動態
      • 專注於開發安替比林聯合治療，以獲得更好的臨床效果
      • 政府對學名藥開發的措施和資金推動市場成長
    • 抑制因素
      • 對與安替比林相關的潛在副作用和安全問題的審查和公眾意識的加強影響了消費者的信心和銷售。
      • 採購製造安替比林所需的優質原料並確保穩定供應是一項挑戰，可能會影響生產效率。
    • 機會
      • 醫療保健投資的增加增加了對藥物製劑中安替比林的需求
      • 寵物飼養量的增加擴大了抗毛蟲素在動物醫藥上的應用
      • 人口老化趨勢增加了疼痛管理解決方案中對安比林的需求
    • 任務
      • 管理抗毛蟲產業的供應鏈中斷和原物料價格波動
      • 將最先進的技術進步和創新引入安替比林生產流程
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章安替比林市場：依產品類型

  • 膠囊
  • 可注射的
  • 液體
  • 粉末
  • 藥片

第7章安替比林市場：依應用分類

  • 發炎（藥
  • 關節炎
  • 感冒和流感
  • 退燒
  • 緩解疼痛

第8章安替比林市場：依最終用戶分類

  • 診所
  • 居家護理
  • 醫院
  • 調查機構

第9章安替比林市場：依通路分類

  • 藥局
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第 10 章 Antipilin 市場：依年齡層

  • 成人
  • 老年醫學
  • 小兒科

第11章依治療層級分類的安替比林市場

  • 止痛藥
  • 退燒劑
  • NSAIDs

第12章 美洲反皮林市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太抗毛素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東及非洲抗毛林市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0034

The Antipyrine Market was valued at USD 363.22 million in 2023, expected to reach USD 382.99 million in 2024, and is projected to grow at a CAGR of 4.34%, to USD 489.29 million by 2030.

Antipyrine, a pharmaceutical compound primarily used as an analgesic and antipyretic, has found various applications in the medical field. The necessity for antipyrine arises from its efficacy in alleviating pain and reducing fever, making it an essential component in the formulation of several over-the-counter and prescription medications. The end-use scope primarily includes its incorporation in ear drop solutions to relieve ear pain and inflammation and its potential use in diagnostic applications due to its pharmacokinetic properties. Market insights indicate that the growth of antipyrine is influenced by factors such as increased prevalence of ear infections, rising demand for effective pain management solutions, and advancements in drug delivery systems. A potential opportunity lies in the exploration of antipyrine's role in novel drug combinations and formulations, catering to an expanding consumer base seeking more comprehensive pain relief options. This includes leveraging emerging research in nanotechnology to enhance the bioavailability and efficacy of antipyrine-based medications, particularly for targeted therapies. However, the market faces challenges such as stringent regulatory frameworks, potential side effects associated with prolonged use, and competition from alternative therapies, which can impede growth. To capture emerging opportunities, businesses should focus on innovations in drug delivery and personalized medicine, catering to specific demographic needs. Collaborating with research institutions for in-depth studies on antipyrine's mechanism and discovering new therapeutic indications can lead to breakthroughs, fortifying market presence. Additionally, expanding geographic reach through strategic partnerships in underserved markets could bolster growth. The market is competitive yet promising, urging industry players to remain adaptive and forward-thinking, ensuring compliance and addressing safety concerns while exploring innovative applications to sustain market relevance and leadership.

KEY MARKET STATISTICS
Base Year [2023] USD 363.22 million
Estimated Year [2024] USD 382.99 million
Forecast Year [2030] USD 489.29 million
CAGR (%) 4.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antipyrine Market

The Antipyrine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
    • Escalating demand for over-the-counter antipyrine medications influencing market dynamics
    • Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
    • Government initiatives and funding for the development of generic antipyrine medications boosting market growth
  • Market Restraints
    • The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
    • The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
  • Market Opportunities
    • Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
    • Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
    • Growing need for antipyrine in pain management solutions spurred by aging population trends
  • Market Challenges
    • Managing supply chain disruptions and raw material price volatility in the antipyrine industry
    • Implementing cutting-edge technological advancements and innovation in the antipyrine production process

Porter's Five Forces: A Strategic Tool for Navigating the Antipyrine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antipyrine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antipyrine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antipyrine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antipyrine Market

A detailed market share analysis in the Antipyrine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antipyrine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antipyrine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antipyrine Market

A strategic analysis of the Antipyrine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antipyrine Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Merck & Co., Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Shionogi, Sun Pharmaceutical, Takeda Pharmaceutical Company, and Teva Pharmaceutical Industries.

Market Segmentation & Coverage

This research report categorizes the Antipyrine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Capsules, Injectable, Liquid, Powder, and Tablets.
  • Based on Application, market is studied across Anti-Inflammatory, Arthritis, Cold and Flu, Fever Reduction, and Pain Relief.
  • Based on End User, market is studied across Clinics, Homecare, Hospitals, and Research Institutes.
  • Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
  • Based on Therapeutic Class, market is studied across Analgesics, Antipyretics, and NSAIDs.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of research activities focusing on the anti-inflammatory properties of antipyrine
      • 5.1.1.2. Escalating demand for over-the-counter antipyrine medications influencing market dynamics
      • 5.1.1.3. Enhanced focus on developing combination therapies featuring antipyrine for better clinical outcomes
      • 5.1.1.4. Government initiatives and funding for the development of generic antipyrine medications boosting market growth
    • 5.1.2. Restraints
      • 5.1.2.1. The increasing scrutiny and public awareness of the potential side effects and safety concerns associated with antipyrine, impacting consumer trust and sales
      • 5.1.2.2. The challenges in sourcing and ensuring the consistent supply of high-quality raw materials required for manufacturing antipyrine, which can affect production efficiency
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased demand for antipyrine in pharmaceutical formulations driven by rising healthcare investments
      • 5.1.3.2. Expansion of antipyrine applications in veterinary medicines due to rising pet adoption rates
      • 5.1.3.3. Growing need for antipyrine in pain management solutions spurred by aging population trends
    • 5.1.4. Challenges
      • 5.1.4.1. Managing supply chain disruptions and raw material price volatility in the antipyrine industry
      • 5.1.4.2. Implementing cutting-edge technological advancements and innovation in the antipyrine production process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antipyrine Market, by Product Type

  • 6.1. Introduction
  • 6.2. Capsules
  • 6.3. Injectable
  • 6.4. Liquid
  • 6.5. Powder
  • 6.6. Tablets

7. Antipyrine Market, by Application

  • 7.1. Introduction
  • 7.2. Anti-Inflammatory
  • 7.3. Arthritis
  • 7.4. Cold and Flu
  • 7.5. Fever Reduction
  • 7.6. Pain Relief

8. Antipyrine Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Homecare
  • 8.4. Hospitals
  • 8.5. Research Institutes

9. Antipyrine Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Drug Stores
  • 9.3. Hospital Pharmacies
  • 9.4. Online Pharmacies
  • 9.5. Retail Pharmacies

10. Antipyrine Market, by Age Group

  • 10.1. Introduction
  • 10.2. Adults
  • 10.3. Geriatrics
  • 10.4. Pediatrics

11. Antipyrine Market, by Therapeutic Class

  • 11.1. Introduction
  • 11.2. Analgesics
  • 11.3. Antipyretics
  • 11.4. NSAIDs

12. Americas Antipyrine Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Antipyrine Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Antipyrine Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie
  • 2. Amgen
  • 3. AstraZeneca
  • 4. Bayer
  • 5. Bristol-Myers Squibb
  • 6. Eli Lilly and Company
  • 7. Gilead Sciences
  • 8. GlaxoSmithKline
  • 9. Hoffmann-La Roche
  • 10. Johnson & Johnson
  • 11. Merck & Co.
  • 12. Novartis
  • 13. Novo Nordisk
  • 14. Pfizer
  • 15. Roche
  • 16. Sanofi
  • 17. Shionogi
  • 18. Sun Pharmaceutical
  • 19. Takeda Pharmaceutical Company
  • 20. Teva Pharmaceutical Industries

LIST OF FIGURES

  • FIGURE 1. ANTIPYRINE MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIPYRINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIPYRINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIPYRINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIPYRINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIPYRINE MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIPYRINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIPYRINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIPYRINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIPYRINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIPYRINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIPYRINE MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIPYRINE MARKET SIZE, BY COLD AND FLU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIPYRINE MARKET SIZE, BY FEVER REDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIPYRINE MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIPYRINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIPYRINE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIPYRINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIPYRINE MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIPYRINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIPYRINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIPYRINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANTIPYRINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTIPYRINE MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANTIPYRINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ANTIPYRINE MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANTIPYRINE MARKET SIZE, BY ANTIPYRETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ANTIPYRINE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES ANTIPYRINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTIPYRINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM ANTIPYRINE MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 287. ANTIPYRINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. ANTIPYRINE MARKET, FPNV POSITIONING MATRIX, 2023